Insulin glargine and lixisenatide Subcutaneous and Pamprin Cramp Formula
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Pamprin Cramp Formula and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: acetaminophen / magnesium salicylate / pamabrom
Brand name: Pamprin Cramp Formula
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Pamprin Max
- Insulin glargine and lixisenatide Subcutaneous-Pamprin Max Pain Formula
- Insulin glargine and lixisenatide Subcutaneous-Pamprin Multi-Symptom
- Insulin glargine and lixisenatide Subcutaneous-Pan C 500
- Insulin glargine and lixisenatide Subcutaneous-Pan-2400
- Insulin glargine and lixisenatide Subcutaneous-Panatuss DXP
- Pamprin Cramp Formula-Insulin glargine, recombinant Subcutaneous
- Pamprin Cramp Formula-Insulin glulisine
- Pamprin Cramp Formula-Insulin Glulisine (Cartridges and Pens)
- Pamprin Cramp Formula-Insulin Glulisine (Vials)
- Pamprin Cramp Formula-Insulin glulisine Subcutaneous
- Pamprin Cramp Formula-Insulin human inhaled Inhalation